Graves Orbitopathy
📧 Sign up to get email alerts when something new happens for Graves Orbitopathy.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2023-04-13FDA Approved: TEPEZZA — Supplemental Application (Horizon Therapeutics USA, Inc.)
FDA overview of a supplemental application for TEPEZZA (teprotumumab) by Horizon Therapeutics USA, Inc.; the submission status is AP.